uniQure
QURE
#5325
Rank
โ‚น156.71 B
Marketcap
โ‚น2,259
Share price
0.39%
Change (1 day)
-53.66%
Change (1 year)

uniQure (QURE) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น63.65 Billion

According to uniQure's latest financial reports the company's total liabilities are โ‚น63.65 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

uniQure - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น56.19 B16.29%
2024-12-31โ‚น48.32 B-6.98%
2023-12-31โ‚น51.94 B174.19%
2022-12-31โ‚น18.94 B19.28%
2021-12-31โ‚น15.88 B125.09%
2020-12-31โ‚น7.05 B-21.2%
2019-12-31โ‚น8.95 B35.81%
2018-12-31โ‚น6.59 B-14.15%
2017-12-31โ‚น7.68 B-10.75%
2016-12-31โ‚น8.60 B-3.89%
2015-12-31โ‚น8.95 B120.45%
2014-12-31โ‚น4.06 B42.52%
2013-12-31โ‚น2.84 B554.29%
2012-12-31โ‚น0.43 B-24.35%
2011-12-31โ‚น0.57 B6.82%
2010-12-31โ‚น0.53 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
โ‚น8.084 T 12,599.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น6.538 T 10,171.67%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
โ‚น7.59 B-88.06%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚น34.07 B-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น520.18 B 717.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
โ‚น25.94 B-59.24%๐Ÿ‡บ๐Ÿ‡ธ USA